Skip to main content
. 2022 Apr 21;10:832870. doi: 10.3389/fpubh.2022.832870

Table 5.

Possible price tiers based on the criteria of study results, quality of evidence, and comparator.

Study design Study quality Type of positive effect Extent of the (additional) effect Comparator Price tier
Not appropriate* Irrelevant Not reimb.
Appropriate* Not according to best practice Health effect OR other care effect only Irrelevant Not reimb.
Health effect AND other care effect Irrelevant Tier 1
According to best practice Other care effect (health comparable) Irrelevant Tier 1
Health effect (and possibly other care effect as well) Small No DIHA or DiHA tier 1 Tier 1
DiHA tier 2 Tier 2
Considerable/substantial No DiHA Tier 2
DiHA tier 1/2 Tier 3
DiHA tier 3 Tier 4
*

Low/middle/high depending on the requirement according to Table 2.